drugset / Trial / NCT01749046

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

NCT01749046 ↗

Phase 3 Completed 224 enrolled Valexfarm
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine weather Remegal in fixed dosage 1500 mg/daily is effictive and safe in patients with epilepsy with partial seizures

Timeline

Start
2012-03
Primary completion
2013-10
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Remegal Unknown 1500 mg —